Rheumatology

Large-scale robust analyses link lupus genetic predisposition to distinct clinical manifestations across biobank and patient cohorts.

IL-26 is emerging as a relevant inflammatory signal in multiple autoimmune diseases, shaping disease-specific immune responses.

Transverse tibial transport improved limb salvage outcomes in recalcitrant diabetic foot ulcers among six patients in an international case series.

AI can simplify complex rheumatology literature, making it easier for patients to understand essential health information.

Racial disparities continue to affect kidney transplant outcomes in patients with SLE, even after the 2014 revision of the Kidney Allocation System designed to improve organ distribution equity.

Methotrexate use does not appear to increase the risk or accelerate the progression of interstitial lung disease in patients with rheumatoid arthritis.

At ACR 2025, early data of CTA313, a universal CD19/BCMA CAR-T therapy, demonstrate safety and strong responses in refractory lupus, offering hope for durable remission.

New research presented at ACR 2025 shows GLP-1 receptor agonists, used for diabetes and obesity, may reduce rheumatoid arthritis flares and inflammation.